Fibrin Formation and Degradation in Patients With Arteriosclerotic Disease

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Circulation

• Publication date

  1994-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.90.6.2679PMID 7994808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum lipoproteins and hemostatic function in intermittent claudication.

  1993cited by this paper
• Prothrombin Activation Fragment 1 + 2 and Thrombin Antithrombin III Complexes in Patients with Angina Pectoris: Relation to the Presence and Severity of Coronary Atherosclerosis

  1993cited by this paper
• Coagulation system activation and increase of D‐dimer levels in peripheral arterial occlusive disease

  1993cited by this paper
• Laboratory markers of coagulation activation.

  1993cited by this paper
• Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin.

  1993cited by this paper
• Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack.

  1993cited by this paper
• Blood Viscosity, Fibrinogen, and Activation of Coagulation and Leukocytes in Peripheral Arterial Disease and the Normal Population in the Edinburgh Artery Study

  1993cited by this paper
• Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis.

  1993cited by this paper
• Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease.

  1993cited by this paper
• Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

  1993cited by this paper
• B‐Mode Ultrasound in Clinical Trials Answers and Questions

  1993cited by this paper
• Increased thrombin-antithrombin III complexes after 1 h of physical exercise.

  1992cited by this paper
• Antithrombotic therapy in peripheral arterial occlusive disease.

  1992cited by this paper
• Prevalence and Determinants of Carotid Atherosclerosis in a General Population

  1992cited by this paper
• Heart Disease: A Textbook of Cardiovascular Medicine

  1992cited by this paper
• Antithrombotic therapy in peripheral arterial occlusive disease.

  1992cited by this paper
• Review: Stratton Lecture. Thrombosis and atherogenesis: molecular connections.

  1992cited by this paper
• D-Dimer and Thrombin-Antithrombin III Complexes in Patients with Clinically Suspected Pulmonary Embolism

  1992cited by this paper
• Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

  1992cited by this paper
• Which factors affect high D-dimer levels in the elderly?

  1991cited by this paper
• Determination of Human Prothrombin Activation Fragment 1+2 in Plasma with an Antibody against a Synthetic Peptide

  1991cited by this paper
• Occult aortic aneurysm

  1991cited by this paper
• Hypoxia induces endothelial cell synthesis of membrane-associated proteins.

  1991cited by this paper
• Prothrombin fragment 1 + 2, thrombin–antithrombin III complexes and D‐dimers in acute deep vein thrombosis: effects of heparin treatment

  1991cited by this paper
• Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1 + 2 measurements.

  1991cited by this paper
• Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors.

  1990cited by this paper
• Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action.

  1990cited by this paper
• Plasma D Dimer: A Useful Marker of Fibrin Breakdown in Renal Failure

  1989cited by this paper
• Serpin receptor 1: a hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes.

  1989cited by this paper
• Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay

  1988cited by this paper
• Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions.

  1987cited by this paper
• Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

  1987cited by this paper
• Markers of thrombotic activity in arterial disease.

  1987cited by this paper
• Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.

  1987cited by this paper
• Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.

  1986cited by this paper
• Ultrasound in the study of atherosclerosis.

  1986cited by this paper
• Thrombinemia during percutaneous transluminal angioplasty of chronic femoral artery occlusions.

  1986cited by this paper
• Fibrinopeptide A excretion in urine in patients with atherosclerotic artery disease.

  1985cited by this paper
• Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.

  1985cited by this paper
• Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death.

  1984cited by this paper
• Ultrasound of the abdominal aorta.

  1984cited by this paper
• Contribution of thrombogenic factors to the pathogenesis of atherosclerosis.

  1983cited by this paper
• Putative atherogenic factors in patients with chronic renal failure.

  1983cited by this paper
• Measurement of Crosslinked Fibrin Degradation Products – An Immunoassay Using Monoclonal Antibodies

  1983cited by this paper
• Catabolism and excretion of fibrinopeptide-A.

  1982cited by this paper
• [The fibrin and plasma-protein content of human thrombi].

  1979cited by this paper
• Exercise stress testing.

  1977cited by this paper
• Measurement of fibrinopeptide A in human blood.

  1974cited by this paper
• Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.

  1974cited by this paper
• Lehrbuch und Atlas der Angiologie : Erkrankungen der Arterien, Venen, Kapillaren und Lymphgefässe der Gliedmassen : Diagnose und Therapie, Anatomie, Physiologie, Pathologische Anatomie und Pathophysiologie

  1970cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper
• Pathophysiology and Natural History the Prevalence of Peripheral Arterial Disease in a Defined Population

  year unknowncited by this paper

• The Use of Clot Strength as a Predictor of Thrombosis in Peripheral Artery Disease.

  2024cites this paper
• Thrombin as target for prevention of recurrent events after acute coronary syndromes.

  2024cites this paper
• Relationship between serum homocysteine, fibrinogen, lipoprotein-a level, and peripheral arterial disease: a dose–response meta-analysis

  2022cites this paper
• Epidemiology of Peripheral Artery Disease and Polyvascular Disease

  2021cites this paper
• A study of correlation of d- dimer with severity of peripheral arterial disease in a tertiary care center of North India: Original research article

  2019cites this paper
• The effect of exercise on coagulation and fibrinolysis factors in patients with peripheral arterial disease

  2016influential citation
• SBA recommendations for regional anesthesia safety in patients taking anticoagulants.

  2014cites this paper
• Recomendaciones de SBA para la seguridad en la anestesia regional en uso de anticoagulantes

  2014cites this paper
• Recomendações da SBA para segurança na anestesia regional em uso de anticoagulantes

  2014cites this paper
• APC-PCI complex levels for screening of AAA in patients with peripheral atherosclerosis

  2013cites this paper
• Biomarkers of Peripheral Arterial Disease

  2013cites this paper
• Functional, genetic and biochemical biomarkers of peripheral arterial disease.

  2012cites this paper
• Haemostatic Effects of Stress

  2011cites this paper
• Prothrombin fragments in cardiovascular disease.

  2010cites this paper
• Activated protein C-protein C inhibitor complex in peripheral arterial disease.

  2010cites this paper
• THROMBOELASTOGRAPHY IN THE ASSESSMENT OF COAGULATION CHANGES IN PERIPHERAL VASCULAR DISEASE

  2010cites this paper
• Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology

  2010cites this paper
• Le complexe Protéine C activée - inhibiteur de protéine C dans la maladie artérielle périphérique

  2010cites this paper
• THROMBOPHILIA AND DIRECT THROMBIN INHIBITOR LEPIRUDIN - CLINICAL AND MONITORING ASPECTS

  2010cites this paper
• Activation of Coagulation by Living Donor Kidney Transplants Early After Reperfusion

  2010cites this paper
• The role of fibrinogen and fibrinolysis in peripheral arterial disease.

  2008cites this paper
• The Effects of Aspirin and Nonselective Beta Blockade on the Acute Prothrombotic Response to Psychosocial Stress in Apparently Healthy Subjects

  2008cites this paper
• Aspirin, but not propranolol, attenuates the acute stress-induced increase in circulating levels of interleukin-6: a randomized, double-blind, placebo-controlled study.

  2008cites this paper
• Mild peripheral neuropathy prevents both leg muscular ischaemia and activation of exercise‐induced coagulation in Type 2 diabetic patients with peripheral artery disease

  2007cites this paper
• Rückenmarksnahe Regionalanästhesien und Thrombo - embolie prophylaxe/antithrombotische Medikation* 2. überarbeitete Empfehlung der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin Regional anaesthesia and thromboembolism prophylaxis/anticoagulation - Revised recommendations of the Germ

  2007cites this paper
• D-dimer local expression is increased in symptomatic patients undergoing carotid endarterectomy.

  2007cites this paper
• Smoking, haemostatic factors, and cardiovascular risk.

  2007cites this paper
• D‐dimer identifies stages in the progression of diabetes mellitus from family history of diabetes to cardiovascular complications

  2007cites this paper
• FIBRIN D‐DIMER FRAGMENTS ENHANCE INFLAMMATORY RESPONSES IN MACROPHAGES: ROLE IN ADVANCING ATHEROSCLEROSIS

  2007cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS

  2006cites this paper
• Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms.

  2006cites this paper
• Haemostasis, inflammation and renal function following exercise in patients with intermittent claudication on statin and aspirin therapy

  2006cites this paper
• Activated coagulation during open and endovascular abdominal aortic aneurysm repair.

  2006cites this paper
• Relation between platelet microaggregates and ankle brachial index in patients with peripheral arterial disease.

  2006cites this paper
• Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.

  2005cites this paper
• Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty.

  2005cites this paper
• Blood coagulation and the risk of atherothrombosis: a complex relationship

  2004cites this paper
• [Effects of exercise on markers of hemostatic activation in young survivors of myocardial infarction].

  2004cites this paper
• The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case–control study

  2004cites this paper
• Off-pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results.

  2004cites this paper
• Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index.

  2003cites this paper
• Do Haemostasis Activation Markers that Predict Cardiovascular Disease Exist?

  2003cites this paper
• D-Dimer, Inflammatory Markers, and Lower Extremity Functioning in Patients With and Without Peripheral Arterial Disease

  2003cites this paper
• [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].

  2003cites this paper
• Exercise in claudicants is accompanied by excessive thrombin generation.

  2003cites this paper
• Thrombin-antithrombin complex and the prothrombin fragment in arterial and venous blood of patients with peripheral arterial disease.

  2003cites this paper
• Hemorheology and hemostasis in vascular disease. A pathophysiological review

  2002cites this paper
• Hemorheology and hemostasis in vascular disease. A pathophysiological review.

  2002cites this paper
• A multidisciplinary study of the interrelationships among alcohol consumption, physical activity, haematological profiles and psychological well being

  2002cites this paper
• [Effect of therapy with clopidogrel on walking tolerance and parameters of hemostasis in patients with atherosclerosis of lower extremities and intermittent claudication].

  2002cites this paper
• D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease.

  2002cites this paper
• Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?

  2002cites this paper
• Coagulation system activity before coronary artery bypass surgery for unstable angina.

  2001cites this paper
• Prevalence and significance of thrombophilia in peripheral arterial disease.

  2001cites this paper
• Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart.

  2001cites this paper
• Coagulation System Activity before Coronary Artery Bypass Surgery for Unstable Angina

  2001cites this paper
• Associations between homocysteine and coagulation factors--a cross-sectional study in two populations of central Europe.

  2001cites this paper
• Activation of thrombosis and fibrinolysis following brain infarction.

  2000cites this paper
• Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandin E1.

  2000cites this paper
• Association of atherosclerosis with low back pain and the degree of disc degeneration.

  1999cites this paper
• Hemostatic Activation under Anticoagulant Treatment: A Comparison of Unfractionated Heparin vs. Nadroparin in the Treatment of Proximal Deep Vein Thrombosis

  1999cites this paper
• Soluble, thrombin-related material in arterial thrombi and plasma studied during catheter-directed intra-arterial thrombolysis.

  1999cites this paper
• Thrombolytic and Antithrombotic Therapies for Acute Coronary Syndromes

  1999cites this paper
• Comparison of haemostatic parameters in arterial and venous blood from patients with peripheral arterial occlusive disease.

  1999cites this paper
• Similar effects of diets high in oleic or linoleic acids on coagulation and fibrinolytic factors in healthy humans.

  1999cites this paper
• Tetranectin Levels in Patients with Acute Myocardial Infarction and Their Alterations during Thrombolytic Treatment

  1998cites this paper
• Severity of tibio peroneal arterial disease: A marker for coronary artery disease

  1998cites this paper
• Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.

  1998cites this paper
• Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.

  1998cites this paper
• Pharmacologic reduction of factor XIII activity and fibrinogenemia in patients with peripheral arterial occlusive disease

  1998cites this paper
• Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease.

  1998cites this paper
• Severity of tibio peroneal arterial disease: A marker for coronary artery disease

  1998cites this paper
• Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association.

  1998cites this paper
• Relationship between Thyroid Hormones and Plasma D-dimer Levels

  1998influential citation
• Reactivation of the coagulation system: rationale for long-term antithrombotic treatment.

  1997cites this paper
• Diet and haemostatic processes

  1997cites this paper
• Mild Hyperhomocysteinemia and Hemostatic Factors in Patients with Arterial Vascular Diseases

  1997cites this paper
• Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.

  1997cites this paper
• Rebound after cessation of oral anticoagulant therapy: the biochemical evidence

  1996cites this paper
• The contribution of thrombosis to the clinical expression of coronary atherosclerosis.

  1996cites this paper
• Smoking, Haemostatic Factors and the Severity of Aorto-lliac and Femoro-Popliteal Disease

  1996cites this paper
• Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease

  1996cites this paper
• Increased circulating plasminogen activator inhibitor-1 in patients with patent femoro-distal venous bypass.

  1996cites this paper
• Balanced activation of coagulation and fibrinolysis after a 2-h triathlon.

  1995cites this paper
• Coronary plaque disruption.

  1995cites this paper
• Determinants of fibrin D-dimer in the Edinburgh Artery Study.

  1995cites this paper
• Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model.

  1995cites this paper
• Blood Coagulation and Fibrinolysis Activation during Sudden Arterial Occlusion of Lower Extremities – an Association with Ischemia and Patient Outcome

  1995cites this paper